CCL2 and obesity disorder: The decrease of MCP-1 after bariatric surgery as an indication of anti-inflammatory effect might offer subsequent protection from obesity-related comorbidities such as insulin resistance, ACVD, and maybe some types of cancer, which are all associated with obesity.